TITLE

Neuroprotection of Ischemic Brain by Vascular Endothelial Growth Factor Is Critically Dependent on Proper Dosage and May Be Compromised by Angiogenesis

AUTHOR(S)
Panya S. Manoonkitiwongsa
PUB. DATE
June 2004
SOURCE
Journal of Cerebral Blood Flow & Metabolism;Jun2004, Vol. 24 Issue 6, p693
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
SUMMARY:: Vascular endothelial growth factor (VEGF) is currently considered a potential pharmacologic agent for stroke therapy because of its strong neuroprotective and angiogenic capacities. Nonetheless, it is unclear how neuroprotection and angiogenesis by exogenous VEGF are related and whether they are concurrent events. In this study, the authors evaluated by stereology the effect of VEGF on neuronal and vascular volume densities of normal and ischemic brain cortices of adult male Sprague-Dawley rats. Ischemia was induced by a 4-hour occlusion of the middle cerebral artery. Low, intermediate, and high doses of VEGF165 were infused through the internal carotid artery for 7 days by an indwelling osmotic pump. The low and intermediate doses, which did not induce angiogenesis, significantly promoted neuroprotection of ischemic brains and did not damage neurons of normal brains. In contrast, the high dose that induced angiogenesis showed no neuroprotection of ischemic brains and damaged neurons of normal brains. These findings suggest that in vivo neuroprotection of ischemic brains by exogenous VEGF does not necessarily occur simultaneously with angiogenesis. Instead, neuroprotection may be greatly compromised by doses of VEGF capable of inducing angiogenesis. Stroke intervention efforts attempting to induce neuroprotection and angiogenesis concurrently through VEGF monotherapy should be approached with caution.
ACCESSION #
13498121

 

Related Articles

  • Magnetic resonance imaging of brain angiogenesis after stroke. Seevinck, Peter; Deddens, Lisette; Dijkhuizen, Rick // Angiogenesis;Jun2010, Vol. 13 Issue 2, p101 

    Stroke is a major cause of mortality and long-term disability worldwide. The initial changes in local perfusion and tissue status underlying loss of brain function are increasingly investigated with noninvasive imaging methods. In addition, there is a growing interest in imaging of processes...

  • Coupling of angiogenesis and neurogenesis in cultured endothelial cells and neural progenitor cells after stroke. Hua Teng; Zheng Gang Zhang; Lei Wang; Rui Lan Zhang; Li Zhang; Morris, Dan; Gregg, Sara R.; Zhenhua Wu; Jiang, Angela; Mei Lu; Zlokovic, Berislav; Chopp, Michael // Journal of Cerebral Blood Flow & Metabolism;Apr2008, Vol. 28 Issue 4, p764 

    Angiogenesis and neurogenesis are coupled processes. Using a coculture system, we tested the hypothesis that cerebral endothelial cells activated by ischemia enhance neural progenitor cell proliferation and differentiation, while neural progenitor cells isolated from the ischemic subventricular...

  • Ischemic stroke and intracranial hemorrhage in glioma patients on antiangiogenic therapy. Fraum, Tyler; Kreisl, Teri; Sul, Joohee; Fine, Howard; Iwamoto, Fabio // Journal of Neuro-Oncology;Nov2011, Vol. 105 Issue 2, p281 

    Bevacizumab, a monoclonal antibody against vascular endothelial growth factor (VEGF), recently received FDA approval for recurrent glioblastoma. Additionally, several VEGF receptor (VEGFR) tyrosine kinase inhibitors (TKIs) have entered trials for recurrent glioma. Phase II studies of bevacizumab...

  • VEGF protein associates to neurons in remote regions following cortical infarct. Stowe, Ann M.; Plautz, Erik J.; Eisner-Janowicz, Ines; Frost, Shawn B.; Barbay, Scott; Zoubina, Elena V.; Dancause, Numa; Taylor, Michael D.; Nudo, Randolph J. // Journal of Cerebral Blood Flow & Metabolism;Jan2007, Vol. 27 Issue 1, p76 

    Vascular endothelial growth factor (VEGF) is thought to contribute to both neuroprotection and angiogenesis after stroke. While increased expression of VEGF has been demonstrated in animal models after experimental ischemia, these studies have focused almost exclusively on the infarct and...

  • The role of VEGF/VEGFR2 signaling in peripheral stimulation-induced cerebral neurovascular regeneration after ischemic stroke in mice. Li, Wen-Lei; Fraser, Jamie; Yu, Shan; Zhu, Jian; Jiang, Ya-Jun; Wei, Ling // Experimental Brain Research;Oct2011, Vol. 214 Issue 4, p503 

    Ischemic stroke is a major cause of mortality and morbidity worldwide but effective treatments are limited. Strategies to enhance neurovascular remodeling following stroke provide promising opportunities to improve tissue repair and functional recovery. We have previously demonstrated that...

  • Current Insights on the Biology and Clinical Aspects of VEGF Regulation. Birk, Daniel M.; Barbato, Joel; Mureebe, Leila; Chaer, Rabih A. // Vascular & Endovascular Surgery;Dec2008/Jan2009, Vol. 42 Issue 6, p517 

    Vascular endothelial growth factor (VEGF) is a key molecule that orchestrates the formation and function of vascular networks. Impaired regulation of angiogenesis is implicated in a number of pathologic states. For instance, neoplasias exhibit uncontrolled angiogenesis, whereas ischemia and...

  • Evolving Strategies in Manipulating VEGF/VEGFR Signaling for the Promotion of Angiogenesis in Ischemic Muscle. Uchida, C.; Haas, T. L. // Current Pharmaceutical Design;2/1/2009, Vol. 15 Issue 4, p411 

    Peripheral artery disease is characterized by reduced blood flow to the lower limb, resulting in chronic ischemia in these muscles, which can lead to eventual amputation of the affected limb. Stimulation of angiogenesis in the ischemic region would be of therapeutic benefit; however, attempts to...

  • Cell and Gene Therapy Approaches for Cardiac Vascularization. Melly, Ludovic; Boccardo, Stefano; Eckstein, Friedrich; Banfi, Andrea; Marsano, Anna // Cells (2073-4409);Dec2012, Vol. 1 Issue 4, p961 

    Despite encouraging preclinical results for therapeutic angiogenesis in ischemia, a suitable approach providing sustained, safe and efficacious vascular growth in the heart is still lacking. Vascular Endothelial Growth Factor (VEGF) is the master regulator of angiogenesis, but it also can easily...

  • Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia. Jewon Ryu; Cheol-Whan Lee; Kyung-Hee Hong; Jin-Ae Shin; Sun-Hee Lim; Park, Chan-Sik; Jiyeon Shim; Ki Byung Nam; Kee-Joon Choi; You-Ho Kim; Ki Hoon Han // Cardiovascular Research;May2008, Vol. 78 Issue 2, p333 

    Aims: The present study investigated the detailed mechanism by which fractalkine (Fkn), a CX3C chemokine, induces angiogenesis and its functional implication in alleviating ischaemia in vivo.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics